Matrix metalloproteinase 1: a better biomarker for squamous cell carcinoma by multiple microarray analyses.

BACKGROUND The present study aimed to validate MMP1 role in the development of squamous cell carcinoma (SCC) by bioinformatics methods. METHODS Gene expression data of 10 GSE series (5 HNSCCs and 5 cSCCs) were obtained from the Gene Expression Omnibus (GEO) database and used to identify differentially expressed genes (DEGs). RESULTS Higher expression of MMP1 was found rank number one in 9/10 GSE series of SCC. MMP1 was mainly focused on Gene Ontology (GO) terms of collagen catabolic process, extracellular matrix disassembly. The analysis results of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways mainly involved Rheumatoid arthritis, Bladder cancer and Pathways in cancer. Also, MMP1 was identified as a hub protein in the PPI network by using Cytoscape software. In addition, others MMPs members of family were analyzed. CONCLUSIONS These results suggested that MMP1 may be pivotal to the transition from normal skin to premalignant lesions to SCC, thus representing a potential therapeutic target gene of diagnosis and prevention in SCC.

[1]  M. Moses,et al.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H. Vrieling,et al.  Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients , 2013, BMC Cancer.

[3]  N. Hempel,et al.  Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells. , 2015, Biochimica et biophysica acta.

[4]  Ming-Tsang Wu,et al.  Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma , 2016, Scientific Reports.

[5]  I. Rimann,et al.  Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination. , 2013, Cancer research.

[6]  Yuan Huang,et al.  Expression of STAT3, MMP-1 and TIMP-1 in gastric cancer and correlation with pathological features. , 2012, Molecular medicine reports.

[7]  N. D’Silva,et al.  Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. , 2008, Cancer research.

[8]  J. Carucci,et al.  Gene expression profiling of the leading edge of cutaneous squamous cell carcinoma (SCC): IL-24 driven MMP-7 , 2013, The Journal of investigative dermatology.

[9]  F. Modolo,et al.  Immunohistochemical expression of matrix metalloproteinase‐1, matrix metalloproteinase‐2 and matrix metalloproteinase‐9, myofibroblasts and Ki‐67 in actinic cheilitis and lip squamous cell carcinoma , 2015, International journal of experimental pathology.

[10]  Amy Y. Chen,et al.  Current treatment of head and neck squamous cell cancer , 2014, Journal of surgical oncology.

[11]  R. S. Padilla,et al.  Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression. , 2010, Archives of dermatology.

[12]  Li Mao,et al.  Transcriptomic dissection of tongue squamous cell carcinoma , 2008, BMC Genomics.

[13]  Y. Hu,et al.  MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma. , 2016, Cancer letters.

[14]  J. Jankiewicz-Wika,et al.  Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer. , 2002, Thyroid : official journal of the American Thyroid Association.

[15]  J. Rutter,et al.  Interstitial collagenases as markers of tumor progression. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  O. Topolcan,et al.  Analysis of preoperative serum levels of MMP1, -2, and -9 in patients with site-specific head and neck squamous cell cancer. , 2014, Anticancer research.

[17]  C. Van Waes,et al.  Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  James T. Elder,et al.  Distinct gene expression profiles of viral- and non-viral associated Merkel cell carcinoma revealed by transcriptome analysis , 2012, The Journal of investigative dermatology.

[19]  C. Gialeli,et al.  Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.

[20]  Christopher M. Overall,et al.  Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.

[21]  L. Ellisen,et al.  The molecular pathogenesis of head and neck squamous cell carcinoma. , 2012, The Journal of clinical investigation.

[22]  S. Rha,et al.  Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma. , 2012, Experimental and molecular pathology.

[23]  D. Uzunaslan,et al.  Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival , 2013, Journal of Cancer Research and Clinical Oncology.

[24]  G. Filosa,et al.  Actinic keratosis and squamous cell carcinoma: clinical and pathological features. , 2015, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[25]  D. Lin,et al.  Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients. , 2010, Lung cancer.

[26]  N. D’Silva,et al.  Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma , 2013, Journal of dental research.

[27]  Panomwat Amornphimoltham,et al.  Fibroblasts and extracellular matrix differently modulate MMP activation by primary and metastatic head and neck cancer cells , 2012, Medical Oncology.

[28]  J. Chen,et al.  BMP-6 inhibits the metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression. , 2016, Oncology reports.

[29]  R. Mangues,et al.  Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma. , 2012, Carcinogenesis.

[30]  Stuart M. Brown,et al.  Selection and validation of differentially expressed genes in head and neck cancer , 2004, Cellular and Molecular Life Sciences CMLS.

[31]  H. Fillmore,et al.  Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway , 2011, Journal of Neuro-Oncology.

[32]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[33]  R. Hamoudi,et al.  Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling , 2013, British Journal of Cancer.

[34]  C. Der,et al.  Overexpression of Collagenase 1 (MMP-1) Is Mediated by the ERK Pathway in Invasive Melanoma Cells , 2004, Journal of Biological Chemistry.

[35]  E. Petricoin,et al.  Functional Protein Pathway Activation Mapping of the Progression of Normal Skin to Squamous Cell Carcinoma , 2012, Cancer Prevention Research.

[36]  Linbo Liu,et al.  Identification of genes and signaling pathways associated with squamous cell carcinoma by bioinformatics analysis , 2015, Oncology letters.

[37]  Cristina M. Pinto,et al.  Retracted: Frequent genetic and biochemical alterations of the PI 3‐K/AKT/PTEN pathway in head and neck squamous cell carcinoma , 2005, International journal of cancer.

[38]  S. Eschrich,et al.  The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis , 2008, BMC Medical Genomics.

[39]  K. Pitman,et al.  Prognostic biomarkers for HNSCC using quantitative real‐time PCR and microarray analysis: β‐tubulin isotypes and the p53 interactome , 2014, Cytoskeleton.

[40]  Xinmin Li,et al.  Molecular discrimination of cutaneous squamous cell carcinoma from actinic keratosis and normal skin , 2011, Modern Pathology.

[41]  A. Colevas.  Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  A. Sinha,et al.  Systematic comparison of nonmelanoma skin cancer microarray datasets reveals lack of consensus genes , 2009, The British journal of dermatology.

[43]  W. Sterry,et al.  Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling , 2006, Molecular Cancer.

[44]  Ruud H. Brakenhoff,et al.  The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.

[45]  Thiennu H. Vu,et al.  Matrix metalloproteinases: effectors of development and normal physiology. , 2000, Genes & development.

[46]  Lue Ping Zhao,et al.  Gene Expression Profiling Identifies Genes Predictive of Oral Squamous Cell Carcinoma , 2008, Cancer Epidemiology Biomarkers & Prevention.

[47]  R. Khokha,et al.  Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development , 2003, British Journal of Cancer.